search
Back to results

Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy (PRORHEM)

Primary Purpose

Colorectal Neoplasms, Colorectal Neoplasms Malignant, Colorectal Neoplasms, Benign

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Robotic right hemicolectomy
Laparoscopic right hemicolectomy
Sponsored by
Jeremy Meyer
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Colorectal Neoplasms

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Adult patients requiring elective minimally invasive RHC for polyps not amenable to endoscopic resection or for cTis-T3 Nx M0 cancer of the right colon (including cancer of the appendix, caecum, ascending colon and hepatic flexure). Exclusion Criteria: Not scheduled for minimally invasive RHC (refuses surgery and/or planned open approach) Emergency surgery Hereditary colorectal cancer Inflammatory bowel disease Synchronous resection of (an)other organ(s) Synchronous surgical procedure (including more extended resection of the lower gastrointestinal tract) cT4 cM+ History of laparotomy Pregnancy No anastomosis planned Unable to provide informed consent No informed consent

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Robotic right hemicolectomy

    Laparoscopic right hemicolectomy

    Arm Description

    Robotic right hemicolectomy with intracorporeal anastomosis and extraction through a C-section (fully minimally invasive right hemicolectomy)

    Laparoscopic right hemicolectomy with extracorporeal anastomosis and extraction through midline (standard of care)

    Outcomes

    Primary Outcome Measures

    Time to first passage of faeces
    Measured in hours, starting at the skin closure of the index surgery

    Secondary Outcome Measures

    Duration of surgery
    Measured in minutes
    Blood loss
    Measured in ml
    Intra-operative transfusion
    Number of patients who received blood and/or blood products transfusion
    Intra-operative complication
    Number of patients who experienced a complication during the index surgery
    Conversion to open surgery
    Number of patients who had conversion to open surgery; defined as an extraction site longer than 10cm
    Length of the extraction site
    Measured in centimeters
    Creation of a stoma
    Number of patients who received a stoma during the index surgery
    Hb, WBC and CRP
    Blood tests
    Time to first passage of flatus
    Measured in hours, starting at the skin closure of the index surgery
    In-hospital postoperative ileus
    Number of patients who experienced a post-operative ileus which required the insertion of a nasogastric tube
    Length of stay
    Measured in days
    Post-operative morbidity
    Number of patients who experienced post-operative morbidity, as measured by the Clavien-Dindo scale
    Surgical site infection
    Number of patients who experienced surgical site infection
    Anastomotic leak
    Number of patients who experienced anastomotic leak, with radiological and/or surgical confirmation
    Re-intervention
    Number of patients who required a surgical re-intervention associated with the index surgery
    Mortality
    Number of patients who experienced mortality
    Proximal margin
    Measured in centimeters, on the operative specimen of the index surgery
    Distal margin
    Measured in centimeters, on the operative specimen of the index surgery
    Harvested lymph nodes
    Number of harvested lymph nodes, on the operative specimen of the index surgery
    Histology of the tumor/polyp
    Type of cancer and/or polyp, based on the operative specimen of the index surgery
    TNM stage
    8th edition of the UICC TNM classification, based on the operative specimen of the index
    Bowel function
    Gastrointestinal Quality of Life Index (GQLI)
    Quality of recovery
    Quality of Recovery-15 (QoR-15) score
    Aesthetic numeric analogue scale (ANA-scale)
    Measuring the patient-reported esthetical aspect of the surgical wounds
    Incidence of incisional hernia
    Overall, and at extraction site; measured clinically and by CT

    Full Information

    First Posted
    September 11, 2023
    Last Updated
    October 2, 2023
    Sponsor
    Jeremy Meyer
    Collaborators
    University Hospital, Geneva, Spital Biel, Switzerland, Hôpital Fribourgeois
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT06067620
    Brief Title
    Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy
    Acronym
    PRORHEM
    Official Title
    Robotic Right Hemicolectomy With Intracorporeal Anastomosis Versus Laparoscopic Right Hemicolectomy With Extracorporeal Anastomosis (PRORHEM): a Randomized Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    January 1, 2024 (Anticipated)
    Primary Completion Date
    May 31, 2025 (Anticipated)
    Study Completion Date
    December 31, 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    Jeremy Meyer
    Collaborators
    University Hospital, Geneva, Spital Biel, Switzerland, Hôpital Fribourgeois

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Robotic right hemicolectomy with intra-corporeal anastomosis may have better short-term recovery outcomes and decreased incidence of incisional hernia when compared to the laparoscopic actual standard of care, for similar safety outcomes.
    Detailed Description
    During laparoscopic right hemicolectomy (lapRHC) for cancer or polyp, intra-corporeal anastomosis (ICA) offers better short-term recovery and decreased incidence of incisional hernia (IH) when compared to extra-corporeal anastomosis (ECA). However, because of the technical limitations of laparoscopy, ICA has not gained in wide acceptance and ECA has remained the standard of care. On the contrary, robotics offers improved suturing capacities and facilitates the realization of ICA. Therefore, robotic right hemicolectomy (robRHC) with ICA may have better short-term recovery outcomes and decreased incidence of IH when compared to the laparoscopic actual standard of care. In a randomized controlled trial, we will compare robRHC with ICA with lapRHC with ECA, in terms of recovery of bowel function (time to first passage of faeces). Secondary outcomes will notably include length of stay, incidence of IH, patient-reported esthetical outcomes and safety outcomes (morbidity, mortality, proximal and distal margins, harvested lymph nodes).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Colorectal Neoplasms, Colorectal Neoplasms Malignant, Colorectal Neoplasms, Benign, Colorectal Cancer, Colorectal Polyp, Colorectal Adenoma, Colorectal Adenocarcinoma

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    70 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Robotic right hemicolectomy
    Arm Type
    Experimental
    Arm Description
    Robotic right hemicolectomy with intracorporeal anastomosis and extraction through a C-section (fully minimally invasive right hemicolectomy)
    Arm Title
    Laparoscopic right hemicolectomy
    Arm Type
    Active Comparator
    Arm Description
    Laparoscopic right hemicolectomy with extracorporeal anastomosis and extraction through midline (standard of care)
    Intervention Type
    Procedure
    Intervention Name(s)
    Robotic right hemicolectomy
    Intervention Description
    Robotic right hemicolectomy with intracorporeal anastomosis and extraction through a C-section, using the Da Vinci Xi.
    Intervention Type
    Procedure
    Intervention Name(s)
    Laparoscopic right hemicolectomy
    Intervention Description
    Laparoscopic right hemicolectomy with extracorporeal anastomosis and extraction through midline.
    Primary Outcome Measure Information:
    Title
    Time to first passage of faeces
    Description
    Measured in hours, starting at the skin closure of the index surgery
    Time Frame
    From index surgical procedure (skin closure) until time of first passage of faeces, during hospitalisation, on average during the first 7 post-operative days
    Secondary Outcome Measure Information:
    Title
    Duration of surgery
    Description
    Measured in minutes
    Time Frame
    From skin incision to skin closure, during index surgical procedure
    Title
    Blood loss
    Description
    Measured in ml
    Time Frame
    From skin incision to skin closure, during index surgical procedure
    Title
    Intra-operative transfusion
    Description
    Number of patients who received blood and/or blood products transfusion
    Time Frame
    From skin incision to skin closure, during index surgical procedure
    Title
    Intra-operative complication
    Description
    Number of patients who experienced a complication during the index surgery
    Time Frame
    From skin incision to skin closure, during index surgical procedure
    Title
    Conversion to open surgery
    Description
    Number of patients who had conversion to open surgery; defined as an extraction site longer than 10cm
    Time Frame
    From skin incision to skin closure, during index surgical procedure
    Title
    Length of the extraction site
    Description
    Measured in centimeters
    Time Frame
    At post-operative day 30
    Title
    Creation of a stoma
    Description
    Number of patients who received a stoma during the index surgery
    Time Frame
    From skin incision to skin closure, during index surgical procedure
    Title
    Hb, WBC and CRP
    Description
    Blood tests
    Time Frame
    At post-operative day 1, post-operative day 2, post-operative day 3, post-operative day 4 and post-operative day 5
    Title
    Time to first passage of flatus
    Description
    Measured in hours, starting at the skin closure of the index surgery
    Time Frame
    From index surgical procedure (skin closure) until time of first passage of flatus, during hospitalisation, on average during the first 7 post-operative days
    Title
    In-hospital postoperative ileus
    Description
    Number of patients who experienced a post-operative ileus which required the insertion of a nasogastric tube
    Time Frame
    During hospitalisation, on average during the first 5 post-operative days
    Title
    Length of stay
    Description
    Measured in days
    Time Frame
    From the first day of hospitalisation to the day of discharge, on average during the first 10 post-operative days
    Title
    Post-operative morbidity
    Description
    Number of patients who experienced post-operative morbidity, as measured by the Clavien-Dindo scale
    Time Frame
    From index surgical procedure (skin closure) to post-operative day 30
    Title
    Surgical site infection
    Description
    Number of patients who experienced surgical site infection
    Time Frame
    From index surgical procedure (skin closure) to post-operative day 7 and post-operative day 30
    Title
    Anastomotic leak
    Description
    Number of patients who experienced anastomotic leak, with radiological and/or surgical confirmation
    Time Frame
    From index surgical procedure (skin closure) to post-operative day 30
    Title
    Re-intervention
    Description
    Number of patients who required a surgical re-intervention associated with the index surgery
    Time Frame
    From index surgical procedure (skin closure) to post-operative day 30
    Title
    Mortality
    Description
    Number of patients who experienced mortality
    Time Frame
    From index surgical procedure (skin closure) to post-operative day 30
    Title
    Proximal margin
    Description
    Measured in centimeters, on the operative specimen of the index surgery
    Time Frame
    Within 10 days from the index surgical procedure
    Title
    Distal margin
    Description
    Measured in centimeters, on the operative specimen of the index surgery
    Time Frame
    Within 10 days from the index surgical procedure
    Title
    Harvested lymph nodes
    Description
    Number of harvested lymph nodes, on the operative specimen of the index surgery
    Time Frame
    Within 10 days from the index surgical procedure
    Title
    Histology of the tumor/polyp
    Description
    Type of cancer and/or polyp, based on the operative specimen of the index surgery
    Time Frame
    Within 10 days from the index surgical procedure
    Title
    TNM stage
    Description
    8th edition of the UICC TNM classification, based on the operative specimen of the index
    Time Frame
    Within 10 days from the index surgical procedure
    Title
    Bowel function
    Description
    Gastrointestinal Quality of Life Index (GQLI)
    Time Frame
    At post-operative day 30 and post-operative year 1
    Title
    Quality of recovery
    Description
    Quality of Recovery-15 (QoR-15) score
    Time Frame
    At post-operative hour 12, post-operative day 1, post-operative day 2, post-operative day 3, post-operative day 4, post-operative day 5 and post-operative day 7
    Title
    Aesthetic numeric analogue scale (ANA-scale)
    Description
    Measuring the patient-reported esthetical aspect of the surgical wounds
    Time Frame
    At post-operative day 30 and post-operative year 1
    Title
    Incidence of incisional hernia
    Description
    Overall, and at extraction site; measured clinically and by CT
    Time Frame
    At post-operative year 1

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Adult patients requiring elective minimally invasive RHC for polyps not amenable to endoscopic resection or for cTis-T3 Nx M0 cancer of the right colon (including cancer of the appendix, caecum, ascending colon and hepatic flexure). Exclusion Criteria: Not scheduled for minimally invasive RHC (refuses surgery and/or planned open approach) Emergency surgery Hereditary colorectal cancer Inflammatory bowel disease Synchronous resection of (an)other organ(s) Synchronous surgical procedure (including more extended resection of the lower gastrointestinal tract) cT4 cM+ History of laparotomy Pregnancy No anastomosis planned Unable to provide informed consent No informed consent
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jeremy Meyer, MD, MD-PhD
    Phone
    +41795533248
    Email
    jeremy.meyer@hcuge.ch
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Christian Toso, MD, PhD
    Organizational Affiliation
    University Hospitals of Geneva
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy

    We'll reach out to this number within 24 hrs